{"transactions":[{"id":4627547,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":52699,"kind":"person","name":"PALUMBO JOHN R","position":1,"cik":"0001251475","reported_name":"PALUMBO JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-09-28T20:07:33.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the second anniversary of the grant date."}],"balance_after":66500,"source":{"system":"sec-edgar","filing":"0001104659-26-111353","document":"tm2626098-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111353/tm2626098-4_4seq1.xml","form_type":"4"}},{"id":4627545,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2025-04-28","expiration_date":"2025-09-18","underlying":"Common Stock","underlying_shares":8435},"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627544,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":250,"price":1000,"value":250000.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2024-02-21","expiration_date":"2025-09-18","underlying":"Common Stock","underlying_shares":11760},"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627543,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."}],"balance_after":57717,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627542,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":8435,"price":16.6,"value":140021.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations."},{"field":"shares","element":"transactionShares","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"AKS Family Partners L.P.'s 100 shares of Series D-2 Preferred Stock automatically converted into 6,025 shares of Common Stock on September 18, 2025, at a conversion price of $16.60 per share. AKS Family Partners L.P. also received 2,410 shares of Common Stock in respect of accrued and unpaid dividends on the Series D-2 Preferred Stock, for a total of 8,435 shares of Common Stock."}],"balance_after":26341,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627541,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:07:06.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":11760,"price":40.4,"value":475104.0,"ownership":{"direct":false,"nature":"By AKS Family Partners L.P."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to the Second Amended and Restated Certificates of Designation of Preferences, Rights and Limitations of the Series C Preferred Stock and the Series D-2 Preferred Stock filed with the Secretary of State of the State of Delaware, the mandatory conversion period of all outstanding shares of each such series was accelerated, and such shares automatically converted into shares of Common Stock effective September 18, 2025, together with all accrued and unpaid dividends, including dividend shares, subject to certain beneficial ownership limitations."},{"field":"shares","element":"transactionShares","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"AKS Family Partners L.P.'s 250 shares of Series C Preferred Stock automatically converted into 6,189 shares of Common Stock on September 18, 2025, at a conversion price of $40.40 per share. AKS Family Partners L.P. also received 5,571 shares of Common Stock in respect of accrued and unpaid dividends on the Series C Preferred Stock, for a total of 11,760 shares of Common Stock. The conversion occurred after the 20-for-1 reverse stock split effected on August 28, 2025, and all share amounts and prices are reported on a post-split basis. The Series C Preferred Stock was previously reported on the Reporting Person's Form 4 filed in September 2025 as 123,763 shares on a pre-split, as-converted basis."}],"balance_after":17906,"source":{"system":"sec-edgar","filing":"0001104659-26-111351","document":"tm2626098-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111351/tm2626098-9_4seq1.xml","form_type":"4"}},{"id":4627540,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:06:45.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the second anniversary of the grant date."}],"balance_after":88737,"source":{"system":"sec-edgar","filing":"0001104659-26-111350","document":"tm2626098-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926111350/tm2626098-3_4seq1.xml","form_type":"4"}},{"id":4627539,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2026-09-28T20:06:38.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":false,"shares":40,"price":1000,"value":40000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2023-05-04","expiration_date":"2024-08-04","underlying":"Common Stock","underlying_shares":772},"source":{"system":"sec-edgar","filing":"0001104659-26-111349","document":"tm2626098-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1744499/000110465926111349/tm2626098-7_4seq1.xml","form_type":"4"}},{"id":4627538,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:06:38.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period."}],"balance_after":87582,"source":{"system":"sec-edgar","filing":"0001104659-26-111349","document":"tm2626098-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744499/000110465926111349/tm2626098-7_4seq1.xml","form_type":"4"}},{"id":4627537,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:06:38.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":true,"shares":772,"price":19.1,"value":14745.2,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion."}],"balance_after":33582,"source":{"system":"sec-edgar","filing":"0001104659-26-111349","document":"tm2626098-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744499/000110465926111349/tm2626098-7_4seq1.xml","form_type":"4"}},{"id":4627489,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75362,"kind":"person","name":"Franco-Yehuda Chen","position":1,"cik":"0001770681","reported_name":"Franco-Yehuda Chen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:06:11.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a\ntwo-year period."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001104659-26-111348","document":"tm2626098-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770681/000110465926111348/tm2626098-6_4seq1.xml","form_type":"4"}},{"id":4627535,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:06:03.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the second anniversary of the grant date."}],"balance_after":87026,"source":{"system":"sec-edgar","filing":"0001104659-26-111347","document":"tm2626098-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465926111347/tm2626098-2_4seq1.xml","form_type":"4"}},{"id":4627493,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:05:44.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period."}],"balance_after":58965,"source":{"system":"sec-edgar","filing":"0001104659-26-111346","document":"tm2626098-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465926111346/tm2626098-5_4seq1.xml","form_type":"4"}},{"id":4627516,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-2 Preferred Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":false,"shares":30,"price":1000,"value":30000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2023-05-04","expiration_date":"2024-08-04","underlying":"Common Stock","underlying_shares":579},"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":4627515,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":297000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period."}],"balance_after":454432,"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":4627514,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:05:13.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":true,"shares":579,"price":19.1,"value":11058.9,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion."}],"balance_after":157432,"source":{"system":"sec-edgar","filing":"0001104659-26-111343","document":"tm2626098-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465926111343/tm2626098-1_4seq1.xml","form_type":"4"}},{"id":702250,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2026-07-28T21:27:53.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":false,"shares":50,"price":1000,"value":50000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2023-05-04","expiration_date":"2024-08-04","underlying":"Common Stock","underlying_shares":965},"source":{"system":"sec-edgar","filing":"0001104659-26-087626","document":"tm2621505-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465926087626/tm2621505-1_4seq1.xml","form_type":"4"}},{"id":702249,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T21:27:53.000Z","date":"2026-07-23","kind":"purchase","planned":false,"acquired":true,"shares":14430,"price":6.93,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reported shares were acquired pursuant to a Securities Purchase Agreement with the issuer, dated July 22, 2026, at a purchase price of $6.93 per share."}],"balance_after":43026,"source":{"system":"sec-edgar","filing":"0001104659-26-087626","document":"tm2621505-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465926087626/tm2621505-1_4seq1.xml","form_type":"4"}},{"id":702248,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T21:27:53.000Z","date":"2024-08-12","kind":"exercise","planned":false,"acquired":true,"shares":965,"price":19.1,"value":18431.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion."}],"balance_after":28596,"source":{"system":"sec-edgar","filing":"0001104659-26-087626","document":"tm2621505-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465926087626/tm2621505-1_4seq1.xml","form_type":"4"}},{"id":1040256,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T22:03:10.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":29717,"source":{"system":"sec-edgar","filing":"0001104659-25-090097","document":"tm2526001-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465925090097/tm2526001-2_4seq1.xml","form_type":"4"}},{"id":1040143,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T20:08:54.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":32810,"source":{"system":"sec-edgar","filing":"0001104659-25-090007","document":"tm2526001-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925090007/tm2526001-8_4seq1.xml","form_type":"4"}},{"id":1040141,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75362,"kind":"person","name":"Franco-Yehuda Chen","position":1,"cik":"0001770681","reported_name":"Franco-Yehuda Chen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-15T20:07:27.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-25-090004","document":"tm2526001-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925090004/tm2526001-6_4seq1.xml","form_type":"4"}},{"id":1040246,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T20:06:48.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":27737,"source":{"system":"sec-edgar","filing":"0001104659-25-090002","document":"tm2526001-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000110465925090002/tm2526001-5_4seq1.xml","form_type":"4"}},{"id":1040570,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T20:05:15.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":27631,"source":{"system":"sec-edgar","filing":"0001104659-25-089996","document":"tm2526001-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465925089996/tm2526001-3_4seq1.xml","form_type":"4"}},{"id":1040699,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-09-15T18:04:08.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":34750,"source":{"system":"sec-edgar","filing":"0001104659-25-090098","document":"tm2526001-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465925090098/tm2526001-10_4seq1.xml","form_type":"4"}},{"id":1040469,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":68904,"kind":"person","name":"Leisure Lawrence B.","position":1,"cik":"0001642824","reported_name":"Leisure Lawrence B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T16:20:39.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest on the last day of the second-year anniversary after the grant date."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-25-090019","document":"tm2526001-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642824/000110465925090019/tm2526001-9_4seq1.xml","form_type":"4"}},{"id":1040470,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-15T16:08:08.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":156853,"source":{"system":"sec-edgar","filing":"0001104659-25-090006","document":"tm2526001-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465925090006/tm2526001-7_4seq1.xml","form_type":"4"}},{"id":1040471,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T16:06:00.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":30965,"source":{"system":"sec-edgar","filing":"0001104659-25-089997","document":"tm2526001-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465925089997/tm2526001-4_4seq1.xml","form_type":"4"}},{"id":1054711,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2025-08-27T16:30:59.000Z","date":"2025-08-27","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":0.53,"value":21200.0,"ownership":{"direct":true},"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001104659-25-084035","document":"tm2524544-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465925084035/tm2524544-1_4seq1.xml","form_type":"4"}},{"id":1147025,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75362,"kind":"person","name":"Franco-Yehuda Chen","position":1,"cik":"0001770681","reported_name":"Franco-Yehuda Chen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-15T20:02:48.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted shares vest over three years, with one third of such shares vesting on April 27, 2026, and the remaining shares vesting in equal quarterly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date The vesting period shall immediately end, and all shares shall immediately vest, in the event of a change in control of the Registrant (as defined in the Registrant's 2020 Equity incentive Plan, as amended)."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001104659-25-049388","document":"tm2515033-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925049388/tm2515033-2_4seq1.xml","form_type":"4"}},{"id":1246369,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":82821,"kind":"person","name":"KAPLAN JON H.","position":1,"cik":"0001751699","reported_name":"KAPLAN JON H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T16:02:22.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111574,"source":{"system":"sec-edgar","filing":"0001104659-25-016923","document":"tm257590-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751699/000110465925016923/tm257590-1_4seq1.xml","form_type":"4"}},{"id":1305050,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2025-01-10T21:04:16.000Z","date":"2025-01-07","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":1000,"value":100000.0,"ownership":{"direct":false,"nature":"AKS Family Partners L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock."}],"balance_after":0,"derivative":{"exercise_price":0.83,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-25-002530","document":"tm252765-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465925002530/tm252765-1_4seq1.xml","form_type":"4"}},{"id":1365368,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-14T16:15:15.000Z","date":"2024-11-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9092,"value":4546.0,"ownership":{"direct":true},"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001104659-24-118926","document":"tm2428408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924118926/tm2428408-1_4seq1.xml","form_type":"4"}},{"id":1408893,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-12T16:37:42.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8045,"value":4022.5,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-24-099353","document":"tm2423915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924099353/tm2423915-1_4seq1.xml","form_type":"4"}},{"id":1408892,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-12T16:37:42.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8442,"value":4221.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001104659-24-099353","document":"tm2423915-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924099353/tm2423915-1_4seq1.xml","form_type":"4"}},{"id":1411033,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-10T06:00:13.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8,"value":4000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001104659-24-098312","document":"tm2423624-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924098312/tm2423624-1_4seq1.xml","form_type":"4"}},{"id":1411032,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-10T06:00:13.000Z","date":"2024-09-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8401,"value":4200.5,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001104659-24-098312","document":"tm2423624-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924098312/tm2423624-1_4seq1.xml","form_type":"4"}},{"id":1411031,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-10T06:00:13.000Z","date":"2024-09-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8182,"value":4091.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-24-098312","document":"tm2423624-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924098312/tm2423624-1_4seq1.xml","form_type":"4"}},{"id":1420866,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-28T18:12:05.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.88,"value":4400.0,"ownership":{"direct":true},"balance_after":1937059,"source":{"system":"sec-edgar","filing":"0001104659-24-094109","document":"tm2422950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924094109/tm2422950-1_4seq1.xml","form_type":"4"}},{"id":1424458,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:57.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9499,"value":4749.5,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-24-092420","document":"tm2422584-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924092420/tm2422584-2_4seq1.xml","form_type":"4"}},{"id":1424457,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:57.000Z","date":"2024-08-22","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.945,"value":4725.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-24-092420","document":"tm2422584-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924092420/tm2422584-2_4seq1.xml","form_type":"4"}},{"id":1424456,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:57.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9345,"value":4672.5,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-24-092420","document":"tm2422584-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924092420/tm2422584-2_4seq1.xml","form_type":"4"}},{"id":1424245,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:20.000Z","date":"2024-08-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.95,"value":4750.0,"ownership":{"direct":true},"balance_after":1932059,"source":{"system":"sec-edgar","filing":"0001104659-24-092417","document":"tm2422584-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924092417/tm2422584-1_4seq1.xml","form_type":"4"}},{"id":1424244,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:20.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.93,"value":4650.0,"ownership":{"direct":true},"balance_after":1927059,"source":{"system":"sec-edgar","filing":"0001104659-24-092417","document":"tm2422584-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924092417/tm2422584-1_4seq1.xml","form_type":"4"}},{"id":1427933,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:57.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9369,"value":4684.5,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001104659-24-091267","document":"tm2422157-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924091267/tm2422157-2_4seq1.xml","form_type":"4"}},{"id":1427932,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:57.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9197,"value":4598.5,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-24-091267","document":"tm2422157-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924091267/tm2422157-2_4seq1.xml","form_type":"4"}},{"id":1427654,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9,"value":4500.0,"ownership":{"direct":true},"balance_after":1922059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1427653,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.9,"value":2700.0,"ownership":{"direct":true},"balance_after":1917059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1427652,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T16:01:15.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.89,"value":1780.0,"ownership":{"direct":true},"balance_after":1914059,"source":{"system":"sec-edgar","filing":"0001104659-24-091264","document":"tm2422157-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924091264/tm2422157-1_4seq1.xml","form_type":"4"}},{"id":1487241,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T16:02:27.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027."}],"balance_after":1350000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0001104659-24-069618","document":"tm2416654-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924069618/tm2416654-2_4seq1.xml","form_type":"4"}},{"id":1487240,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T16:02:27.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024."}],"balance_after":400000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-24-069618","document":"tm2416654-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924069618/tm2416654-2_4seq1.xml","form_type":"4"}},{"id":1487239,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75375,"kind":"person","name":"Nelson Steven Charles","position":1,"cik":"0002025906","reported_name":"Nelson Steven Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T16:02:27.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-069618","document":"tm2416654-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2025906/000110465924069618/tm2416654-2_4seq1.xml","form_type":"4"}},{"id":1586097,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T21:23:08.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":256193,"source":{"system":"sec-edgar","filing":"0001104659-24-032414","document":"tm248350-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924032414/tm248350-8_4seq1.xml","form_type":"4"}},{"id":1586391,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T21:18:46.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period."}],"balance_after":154744,"source":{"system":"sec-edgar","filing":"0001104659-24-032408","document":"tm248350-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000110465924032408/tm248350-3_4seq1.xml","form_type":"4"}},{"id":1586972,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T21:16:57.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period."}],"balance_after":152620,"source":{"system":"sec-edgar","filing":"0001104659-24-032405","document":"tm248350-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465924032405/tm248350-2_4seq1.xml","form_type":"4"}},{"id":1586486,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T21:15:14.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period."}],"balance_after":194341,"source":{"system":"sec-edgar","filing":"0001104659-24-032397","document":"tm248350-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465924032397/tm248350-1_4seq1.xml","form_type":"4"}},{"id":1586774,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93311,"kind":"person","name":"Ben-David Zvi","position":1,"cik":"0001667943","reported_name":"Ben-David Zvi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-08T16:24:24.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":746035,"source":{"system":"sec-edgar","filing":"0001104659-24-032416","document":"tm248350-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667943/000110465924032416/tm248350-9_4seq1.xml","form_type":"4"}},{"id":1586390,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93305,"kind":"person","name":"ANDERSON RICHARD ALAN","position":1,"cik":"0001266647","reported_name":"ANDERSON RICHARD ALAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T16:22:19.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025."}],"balance_after":320000,"derivative":{"exercise_price":1.68,"underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001104659-24-032413","document":"tm248350-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266647/000110465924032413/tm248350-7_4seq1.xml","form_type":"4"}},{"id":1586389,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93305,"kind":"person","name":"ANDERSON RICHARD ALAN","position":1,"cik":"0001266647","reported_name":"ANDERSON RICHARD ALAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T16:22:19.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company."}],"balance_after":750000,"derivative":{"exercise_price":1.68,"underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001104659-24-032413","document":"tm248350-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266647/000110465924032413/tm248350-7_4seq1.xml","form_type":"4"}},{"id":1586884,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":82821,"kind":"person","name":"KAPLAN JON H.","position":1,"cik":"0001751699","reported_name":"KAPLAN JON H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T16:21:41.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001104659-24-032412","document":"tm248350-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751699/000110465924032412/tm248350-6_4seq1.xml","form_type":"4"}},{"id":1586784,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T16:20:27.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":219290,"source":{"system":"sec-edgar","filing":"0001104659-24-032411","document":"tm248350-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465924032411/tm248350-5_4seq1.xml","form_type":"4"}},{"id":1586771,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-08T16:19:38.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":1912059,"source":{"system":"sec-edgar","filing":"0001104659-24-032409","document":"tm248350-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465924032409/tm248350-4_4seq1.xml","form_type":"4"}},{"id":1606733,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series-C Preferred Stock","published_at":"2024-03-01T21:01:15.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":250,"price":1000,"value":250000.0,"ownership":{"direct":false,"nature":"AKS Family Partnership, L.P"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to beneficial ownership limitations provided for in the offering documents relating to the sale of the Series-C Preferred Stock, each share of Series-C Preferred Stock shall automatically convert into shares of the registrant's common stock at the conversion price of $2.02 upon the earlier of (i) the 15-month anniversary of the effective date of the certificate of designation, or (ii) the consent to conversion by holders of at least 50.1% of the outstanding shares of Series-C Preferred."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to beneficial ownership limitations provided for in the offering documents relating to the sale of the Series-C Preferred Stock, each share of Series-C Preferred Stock shall automatically convert into shares of the registrant's common stock at the conversion price of $2.02 upon the earlier of (i) the 15-month anniversary of the effective date of the certificate of designation, or (ii) the consent to conversion by holders of at least 50.1% of the outstanding shares of Series-C Preferred."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Series C Preferred Stock initially converts into shares of common stock at a conversion price of $2.02. In addition, the holders of Series c Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to seven and a half percent (7.5%) of the number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to fifteen percent (15%) of the number of shares of common stock issuable upon conversion of the Series C Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":250,"derivative":{"exercise_price":2.02,"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-24-029952","document":"tm247605-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465924029952/tm247605-1_4seq1.xml","form_type":"4"}},{"id":1629884,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":94075,"kind":"person","name":"Ben-Kiki Tomer","position":1,"cik":"0002011990","reported_name":"Ben-Kiki Tomer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-21T16:16:56.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principals basis) for the year ending December 31, 2024, the achievement of certain operating expense targets for the years ending December 31, 2024 and December 31, 2025, the ability to generate software value from funds invested and meet product roadmap and the retention of key employees post transaction, subject in each case to the Reporting Person's continued services to the Issuer on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principals basis) for the year ending December 31, 2024, the achievement of certain operating expense targets for the years ending December 31, 2024 and December 31, 2025, the ability to generate software value from funds invested and meet product roadmap and the retention of key employees post transaction, subject in each case to the Reporting Person's continued services to the Issuer on the applicable vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2.55,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-24-026040","document":"tm246888-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2011990/000110465924026040/tm246888-2_4seq1.xml","form_type":"4"}},{"id":1629883,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":94075,"kind":"person","name":"Ben-Kiki Tomer","position":1,"cik":"0002011990","reported_name":"Ben-Kiki Tomer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-21T16:16:56.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":717947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows: 291,742 shares vest immediately, and the remaining 426,205 shares vest over two years in eight equal quarterly amounts, subject to subject to the Reporting Person's continued services to the Issuer on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options vest as follows: 291,742 shares vest immediately, and the remaining 426,205 shares vest over two years in eight equal quarterly amounts, subject to subject to the Reporting Person's continued services to the Issuer on the applicable vesting date."}],"balance_after":717947,"derivative":{"exercise_price":2.55,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":717947},"source":{"system":"sec-edgar","filing":"0001104659-24-026040","document":"tm246888-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011990/000110465924026040/tm246888-2_4seq1.xml","form_type":"4"}},{"id":1901062,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-05-08T20:13:31.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":50,"price":1000,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":50,"derivative":{"exercise_price":3.37,"exercise_date":"2023-05-04","expiration_date":"2026-05-04","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-23-057160","document":"tm2315002-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465923057160/tm2315002-4_4seq1.xml","form_type":"4"}},{"id":1900675,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-05-08T20:12:59.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":40,"price":1000,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":40,"derivative":{"exercise_price":3.37,"exercise_date":"2023-05-04","expiration_date":"2026-05-04","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-23-057159","document":"tm2315002-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057159/tm2315002-3_4seq1.xml","form_type":"4"}},{"id":1901007,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":82821,"kind":"person","name":"KAPLAN JON H.","position":1,"cik":"0001751699","reported_name":"KAPLAN JON H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-05-08T16:12:05.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":30,"price":1000,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":30,"derivative":{"exercise_price":3.37,"exercise_date":"2023-05-04","expiration_date":"2026-05-04","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-23-057158","document":"tm2315002-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751699/000110465923057158/tm2315002-2_4seq1.xml","form_type":"4"}},{"id":1900944,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-2 Preferred Stock","published_at":"2023-05-08T16:11:15.000Z","date":"2023-05-04","kind":"purchase","planned":false,"acquired":true,"shares":30,"price":1000,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date."}],"balance_after":30,"derivative":{"exercise_price":3.37,"exercise_date":"2023-05-04","expiration_date":"2026-05-04","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-23-057156","document":"tm2315002-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465923057156/tm2315002-1_4seq1.xml","form_type":"4"}},{"id":2052461,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-18T17:01:55.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":1200,"price":6.2075,"value":7449.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.23, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":1112059,"source":{"system":"sec-edgar","filing":"0001104659-23-004642","document":"tm233645-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465923004642/tm233645-1_4seq1.xml","form_type":"4"}},{"id":2076673,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-23T21:30:47.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":9872,"price":3.9714,"value":39205.6608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and were effected to pay Federal and State withholding taxes on vested shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $4.12, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":74744,"source":{"system":"sec-edgar","filing":"0001104659-22-129915","document":"tm2233446-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000110465922129915/tm2233446-1_4seq1.xml","form_type":"4"}},{"id":2235706,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93305,"kind":"person","name":"ANDERSON RICHARD ALAN","position":1,"cik":"0001266647","reported_name":"ANDERSON RICHARD ALAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, GM of North America"}}],"security":"Common Stock","published_at":"2022-06-10T19:00:38.000Z","date":"2022-06-09","kind":"disposition_to_issuer","acquired":false,"shares":17957,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were redeemed by the issuer for aggregate proceeds of $170,275, to satisfy certain withholding tax obligations of existing vested restricted stock awards. The redemption of the securities was approved by the Compensation Committee of the issuer and was exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were redeemed by the issuer for aggregate proceeds of $170,275, to satisfy certain withholding tax obligations of existing vested restricted stock awards. The redemption of the securities was approved by the Compensation Committee of the issuer and was exempt pursuant to Rule 16b-3."}],"balance_after":108877,"source":{"system":"sec-edgar","filing":"0001104659-22-070253","document":"tm2218130-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266647/000110465922070253/tm2218130-1_4seq1.xml","form_type":"4"}},{"id":2261452,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75363,"kind":"person","name":"Shaked Yoav","position":1,"cik":"0001744499","reported_name":"Shaked Yoav","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:04:27.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":166193,"source":{"system":"sec-edgar","filing":"0001104659-22-063456","document":"tm2216123-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465922063456/tm2216123-9_4seq1.xml","form_type":"4"}},{"id":2261596,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:01:33.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 33.333% shall vest after 12 months from the grant date, and the remaining shares shall vest in 2 equal instalments every 2 years thereafter."}],"balance_after":84616,"source":{"system":"sec-edgar","filing":"0001104659-22-063447","document":"tm2216123-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000110465922063447/tm2216123-3_4seq1.xml","form_type":"4"}},{"id":2262037,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":28267,"kind":"person","name":"Matheis Dennis","position":1,"cik":"0001817012","reported_name":"Matheis Dennis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T21:01:25.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over three years in 12 equal quarterly installments following the grant date, subject to the Reporting Person's continued services to the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":7.19,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-22-063445","document":"tm2216123-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817012/000110465922063445/tm2216123-2_4seq1.xml","form_type":"4"}},{"id":2261648,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":23682,"kind":"person","name":"STERN ADAM K","position":1,"cik":"0001403497","reported_name":"STERN ADAM K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:00:41.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 33.333% shall vest after 12 months from the grant date, and the remaining shares shall vest in 2 equal instalments every 2 years thereafter."}],"balance_after":124341,"source":{"system":"sec-edgar","filing":"0001104659-22-063443","document":"tm2216123-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403497/000110465922063443/tm2216123-1_4seq1.xml","form_type":"4"}},{"id":2261835,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93311,"kind":"person","name":"Ben-David Zvi","position":1,"cik":"0001667943","reported_name":"Ben-David Zvi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-20T17:04:25.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":346035,"source":{"system":"sec-edgar","filing":"0001104659-22-063457","document":"tm2216123-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667943/000110465922063457/tm2216123-10_4seq1.xml","form_type":"4"}},{"id":2262383,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127103,"kind":"person","name":"STONE RICHARD B","position":1,"cik":"0001063028","reported_name":"STONE RICHARD B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T17:03:39.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over three years in 12 equal quarterly installments following the grant date, subject to the Reporting Person's continued services to the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":7.19,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-22-063453","document":"tm2216123-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1063028/000110465922063453/tm2216123-8_4seq1.xml","form_type":"4"}},{"id":2261591,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93305,"kind":"person","name":"ANDERSON RICHARD ALAN","position":1,"cik":"0001266647","reported_name":"ANDERSON RICHARD ALLAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, GM of North America"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T17:03:13.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over three years in 12 equal quarterly installments following the grant date, subject to the Reporting Person's continued services to the Issuer."}],"balance_after":135000,"derivative":{"exercise_price":7.19,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-22-063452","document":"tm2216123-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266647/000110465922063452/tm2216123-7_4seq1.xml","form_type":"4"}},{"id":2261836,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T17:02:44.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":149290,"source":{"system":"sec-edgar","filing":"0001104659-22-063451","document":"tm2216123-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465922063451/tm2216123-6_4seq1.xml","form_type":"4"}},{"id":2261834,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-20T17:02:08.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":1113259,"source":{"system":"sec-edgar","filing":"0001104659-22-063450","document":"tm2216123-5_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465922063450/tm2216123-5_4seq.xml","form_type":"4"}},{"id":2261943,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-20T17:01:50.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":265926,"source":{"system":"sec-edgar","filing":"0001104659-22-063449","document":"tm2216123-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465922063449/tm2216123-4_4seq1.xml","form_type":"4"}},{"id":2517851,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-10T20:00:53.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":804,"price":19.091,"value":15349.164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.19, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":170926,"source":{"system":"sec-edgar","filing":"0001104659-21-137138","document":"tm2132548-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921137138/tm2132548-1_4seq1.xml","form_type":"4"}},{"id":2519629,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-09T20:51:54.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":800,"price":19.0788,"value":15263.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":838259,"source":{"system":"sec-edgar","filing":"0001104659-21-136496","document":"tm2132400d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921136496/tm2132400d1_4.xml","form_type":"4"}},{"id":2519628,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-09T20:51:54.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":200,"price":19.05,"value":3810.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.09, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":839059,"source":{"system":"sec-edgar","filing":"0001104659-21-136496","document":"tm2132400d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921136496/tm2132400d1_4.xml","form_type":"4"}},{"id":2521487,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-08T18:00:37.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":200,"price":19.06,"value":3812.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.09, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":171730,"source":{"system":"sec-edgar","filing":"0001104659-21-135790","document":"tm2132279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921135790/tm2132279-1_4seq1.xml","form_type":"4"}},{"id":2521486,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-08T18:00:37.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":200,"price":19.08,"value":3816.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.06 to $19.10, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":171930,"source":{"system":"sec-edgar","filing":"0001104659-21-135790","document":"tm2132279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921135790/tm2132279-1_4seq1.xml","form_type":"4"}},{"id":2523012,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T19:00:38.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":7857,"price":18.4907,"value":145281.4299,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.02 to $19.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":839259,"source":{"system":"sec-edgar","filing":"0001104659-21-135188","document":"tm2132090-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921135188/tm2132090-1_4seq1.xml","form_type":"4"}},{"id":2523011,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T19:00:38.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":30483,"price":18.9648,"value":578103.9984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $19.38, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":847116,"source":{"system":"sec-edgar","filing":"0001104659-21-135188","document":"tm2132090-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921135188/tm2132090-1_4seq1.xml","form_type":"4"}},{"id":2524586,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-04T18:00:50.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":8016,"price":19.129,"value":153338.064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.38, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":172130,"source":{"system":"sec-edgar","filing":"0001104659-21-134531","document":"tm2131978-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921134531/tm2131978-1_4seq1.xml","form_type":"4"}},{"id":2524585,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-04T18:00:50.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":4363,"price":19.065,"value":83180.595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.15, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":180146,"source":{"system":"sec-edgar","filing":"0001104659-21-134531","document":"tm2131978-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921134531/tm2131978-1_4seq1.xml","form_type":"4"}},{"id":2526336,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-03T19:00:30.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":41279,"price":18.6648,"value":770464.2792,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.52 to $19.16, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."}],"balance_after":877599,"source":{"system":"sec-edgar","filing":"0001104659-21-133842","document":"tm2131828-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921133842/tm2131828-1_4seq1.xml","form_type":"4"}},{"id":2526335,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-03T19:00:30.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":25804,"price":18.0098,"value":464724.8792,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $18.35, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":918878,"source":{"system":"sec-edgar","filing":"0001104659-21-133842","document":"tm2131828-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921133842/tm2131828-1_4seq1.xml","form_type":"4"}},{"id":2541793,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":134563,"kind":"person","name":"Cohen Oded","position":1,"cik":"0001846154","reported_name":"Cohen Oded","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GM MSK"}}],"security":"Common Stock","published_at":"2021-10-15T17:00:58.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":20000,"price":16.11,"value":322200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.99 to $16.46, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp.(the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":430764,"source":{"system":"sec-edgar","filing":"0001104659-21-126791","document":"tm2130131d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846154/000110465921126791/tm2130131d1_4.xml","form_type":"4"}},{"id":2544502,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93311,"kind":"person","name":"Ben-David Zvi","position":1,"cik":"0001667943","reported_name":"Ben-David Zvi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-12T16:46:43.000Z","date":"2021-10-10","kind":"grant","acquired":true,"shares":369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021."}],"balance_after":251035,"source":{"system":"sec-edgar","filing":"0001104659-21-125375","document":"tm2129692d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667943/000110465921125375/tm2129692d3_4.xml","form_type":"4"}},{"id":2544500,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-12T16:46:20.000Z","date":"2021-10-10","kind":"grant","acquired":true,"shares":695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021."}],"balance_after":944682,"source":{"system":"sec-edgar","filing":"0001104659-21-125373","document":"tm2129692d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921125373/tm2129692d2_4.xml","form_type":"4"}},{"id":2544530,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":127085,"kind":"person","name":"Bacher Dror","position":1,"cik":"0001710439","reported_name":"Bacher Dror","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-12T16:45:46.000Z","date":"2021-10-10","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021."}],"balance_after":184509,"source":{"system":"sec-edgar","filing":"0001104659-21-125371","document":"tm2129692d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710439/000110465921125371/tm2129692d1_4.xml","form_type":"4"}},{"id":2629215,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93311,"kind":"person","name":"Ben-David Zvi","position":1,"cik":"0001667943","reported_name":"Ben-David Zvi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-20T16:31:51.000Z","date":"2021-07-18","kind":"grant","acquired":true,"shares":365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021."}],"balance_after":250666,"source":{"system":"sec-edgar","filing":"0001104659-21-093989","document":"tm2122591-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667943/000110465921093989/tm2122591-4_4seq1.xml","form_type":"4"}},{"id":2629111,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":93305,"kind":"person","name":"ANDERSON RICHARD ALAN","position":1,"cik":"0001266647","reported_name":"ANDERSON RICHARD ALLAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, GM of North America"}}],"security":"Restricted Stock Units","published_at":"2021-07-20T16:31:24.000Z","date":"2021-07-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The shares will vest in twelve equal quarterly installments over a three-year period commencing on the date of grant, subject to the Reporting\nPerson's continued employment by the Issuer."}],"balance_after":126834,"source":{"system":"sec-edgar","filing":"0001104659-21-093987","document":"tm2122591-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266647/000110465921093987/tm2122591-3_4seq1.xml","form_type":"4"}},{"id":2629214,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75372,"kind":"person","name":"Raphael Erez","position":1,"cik":"0001668046","reported_name":"Raphael Erez","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-20T16:31:05.000Z","date":"2021-07-18","kind":"grant","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021."}],"balance_after":943987,"source":{"system":"sec-edgar","filing":"0001104659-21-093983","document":"tm2122591-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668046/000110465921093983/tm2122591-2_4seq1.xml","form_type":"4"}}],"next_cursor":"2021-07-20T16:31:05.000000Z,2629214"}